🔴 Conexeu Sciences is trading 14.71% down today with no clear catalyst identified

Conexeu Sciences is trading at $8.52, down -14.71%, with no clear company-specific catalyst identified.

• The decline reversed its August 18, 2026 close of $9.99, despite recent gains.
• No company-specific announcement, filing, earnings release, or direct catalyst was identified; available coverage lists no significant recent news.
• Biotechnology is stronger on Moderna’s positive cancer-vaccine trial results, so the decline may reflect profit-taking or stock-specific trading pressure after the rally.